Interplay between Alpha/Beta and Gamma Interferons with B, T, and Natural Killer Cells in the Defense against Herpes Simplex Virus Type 1

Journal of Virology

Volumn 78, Issue 8, 2004, Pages 3846-3850

  Vollstedt, Sabine ^a   Arnold, Susi ^a   Schwerdel, Cornelia ^a   Franchini, Marco ^a   Alber, Gottfried ^b   Di Santo, James P ^c   Ackermann, Mathias ^a   Suter, Mark ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHRONIC DISEASE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; INFECTION CONTROL; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TIME; VIRUS INFECTION;

ANIMALS; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM INFECTIONS; DNA, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERFERONS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MEMBRANE PROTEINS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; T-LYMPHOCYTES;

EID: 1842589394     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.8.3846-3850.2004     Document Type: Article

References (49)

1. Adler, H., J. L. Beland, N. C. DelPan, L. Kobzik, R. A. Sobel, and I. J. Rimm. 1999. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J. Neuroimmunol. 93:208-213.
2. Biron, C. A. 2001. Interferons alpha and beta as immune regulators - a new look. Immunity 14:661-664.
3. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
4. Brombacher, F., A. Dorfmuller, J. Magram, W. J. Dai, G. Kohler, A. Wunderlin, K. Palmer-Lehmann, M. K. Gately, and G. Alber. 1999. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11:325-332.
5. Bukowski, J. F., and R. M. Welsh. 1986. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 136:3481-3485.
6. Cantin, E., B. Tanamachi, and H. Openshaw. 1999. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73:3418-3423.
7. Colucci, F., C. Soudais, E. Rosmaraki, L. Vanes, V. L. J. Tybulewicz, and J. P. Di Santo. 1999. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162:2761-2765.
8. Cooper, R. N., A. Irintchev, J. P. Di Santo, M. Zweyer, J. E. Morgan, T. A. Partridge, G. S. Butler-Browne, V. Mouly, and A. Wernig. 2001. A new immunodeficient mouse model for human myoblast transplantation. Hum. Gene Ther. 12:823-831.
9. DiSanto, J. P., W. Muller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 92:377-381.
10. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735-741.
11. Ejercito, P. M., E. D. Kieff, and B. Roizman. 1968. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:357-364.
12. Ellison, A. R., L. Yang, C. Voytek, and T. P. Margolis. 2000. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology 268:17-28.
13. Feldman, L. T., A. R. Ellison, C. C. Voytek, L. Yang, P. Krause, and T. P. Margolis. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. USA 99:978-983.
14. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405-411.
15. Fitzgerald-Bocarsly, P., D. M. Howell, L. Pettera, S. Tehrani, and C. Lopez. 1991. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J. Virol. 65:3151-3160.
16. Franchini, M., C. Abril, C. Schwerdel, C. Ruedl, M. Ackermann, and M. Suter. 2001. Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus. J. Virol. 75:83-89.
17. Granucci, F., C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2:882-888.
18. Grob, P., V. E. C. J. Schijns, M. F. van den Broek, S. P. J. Cox, M. Ackermann, and M. Suter. 1999. Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. J. Virol. 73:4748-4754.
19. Habu, S., K. Akamatsu, N. Tamaoki, and K. Okumura. 1984. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133:2743-2747.
20. Hendrzak, J. A., and P. S. Morahan. 1994. The role of macrophages and macrophage cytokines in host resistance to herpes simplex virus. Immunol. Ser. 60:601-617.
21. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J. Immunol. 166:5448-5455.
22. Hölscher, C., R. Atkinson, B. Ardense, N. Brown, E. Myburgh, G. Alber, and F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957-6966.
23. Kaerber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:480.
24. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
25. Klein, M. A., R. Frigg, E. Flechsig, A. J. Raeber, U. Kalinke, H. Bluethmann, F. Bootz, M. Suter, R. M. Zinkernagel, and A. Aguzzi. 1997. A crucial role for B cells in neuroinvasive scrapie. Nature 390:687-690.
26. Kodukula, P., T. Liu, N. V. Rooijen, M. J. Jager, and R. L. Hendricks. 1999. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162:2895-2905.
27. Lekstrom-Himes, J. A., R. A. LeBlanc, L. Pesnicak, M. Godleski, and S. E. Straus. 2000. Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. J. Virol. 74:6680-6683.
28. Liu, T., K. M. Khanna, B. N. Carriere, and R. L. Hendricks. 2001. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75:11178-11184.
29. Mattner, F., L. Ozmen, F. J. Podlaski, V. L. Wilkinson, D. H. Presky, M. K. Gately, and G. Alber. 1997. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock. Infect. Immun. 65:4734-4737.
30. Mercurio, A. M., G. A. Schwarting, and P. W. Robbins. 1984. Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J. Exp. Med. 160:1114-1125.
31. Minagawa, H., and Y. Yanagi. 2000. Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+ cells: a new model for latency. Arch. Virol. 145:2259-2272.
32. Mueller, S. N., C. M. Jones, C. M. Smith, W. R. Heath, and F. R. Carbone. 2002. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195:651-656.
33. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
34. Pinto, A. J., P. S. Morahan, M. Brinton, D. Stewart, and E. Gavin. 1990. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res. 10:293-298.
35. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165-8168.
36. Roizman, B., and W. Batterson. 1986. Herpesviruses and their replication, p. 607-636. In B. N. Fields and D. M. Knipe (ed.), Fundamental virology. Raven Press, New York, N.Y.
37. Rosmaraki, E., I. Douagi, C. Roth, F. Colucci, A. Cumano, and J. Di Santo. 2001. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31:1900-1909.
38. Rossol-Voth, R., S. Rossol, K. H. Schutt, S. Corridori, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143-147.
39. Ryncarz, A. J., J. Goddard, A. Wald, M.-L. Huang, B. Roizman, and L. Corey. 1999. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J. Clin. Microbiol. 37:1941-1947.
40. Sainz, B., Jr., and W. P. Halford. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76:11541-11550.
41. Schuler, G. 1984. The dendritic, Thy-1-positive cell of murine epidermis: a new epidermal cell type of bone marrow origin. J. Investig. Dermatol. 83:81-82.
42. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337-1344.
43. Smith, P. M., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology 202:76-88.
44. Suter, M., A. M. Lew, P. Grob, G. J. Adema, M. Ackermann, K. Shortman, and C. Fraefel. 1999. BAC-VAC, a novel generation of (DNA) vaccines: a bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 96:12697-12702.
45. Thomas, J., and B. T. Rouse. 1997. Immunopathogenesis of herpetic ocular disease. Immunol. Res. 16:375-386.
46. Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines. New players in the regulation of T cell responses. Immunity 19:641-644.
47. van den Broek, M. F., U. Müller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
48. Vollstedt, S., M. Franchini, G. Alber, M. Ackermann, and M. Suter. 2001. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1. J. Virol. 75:9596-9600.
49. Wagner, E. D., and D. C. Bloom. 1997. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10:419-443.